Remove 2030 Remove Biotech Remove Government
article thumbnail

Pharma & Biotech in 2025: The Top 6 Growth Opportunities Shaping the Future

Frost & Sullivan

However, the industry faces mounting drug pricing challenges as governments and insurers demand cost-effective solutions, pushing pharmaceutical companies to optimize their value propositions. Download our full analysis on the top 6 growth opportunities in pharma and biotech. By 2030, the RLT market is projected to reach $13.07

Biotech 52
article thumbnail

Top 50 Technologies Shaping 2025: Innovations Redefining Growth & Investment

Frost & Sullivan

Investment Outlook : Expect accelerated government incentives and private sector adoption as regulations tighten on industrial emissions. Middle East: Governments are building closed-loop battery recycling ecosystems , attracting global recyclers like Li-Cycle and Umicore. Stay Ahead of the Curve Reserve Your Spot Now!

Biotech 52
article thumbnail

Top 50 Technologies of 2025: Transforming Industries & Driving Strategic Investments

Frost & Sullivan

Middle East: Vision 2030 & Net Zero 2050 are pushing Emirates, Qatar Airways, and Etihad to lead global SAF adoption. APAC: Expected to account for 40% of global SAF demand by 2030 , with Nestes Singapore plant leading production. Regional Insights: India: Government investing in quantum sensing under the National Quantum Mission.

Biotech 52